VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AMS
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AMSAmerican Shared Hospital Services
$1.63$11M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAMSBalance Sheet

American Shared Hospital Services (AMS) Balance Sheet

30Y historyFree accessUpdated daily

The company's financial position appears increasingly vulnerable, as evidenced by a debt-to-equity ratio that has risen to 0.79 alongside a current ratio decline to 0.77 as of 2026Q1.

AMS Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99Dec'98Dec'97Dec'96
Total Current Assets18.27M17.72M26.26M20.46M18.72M15.09M10.85M10.74M9.95M8.89M8.39M6.01M14.25M7.71M15.96M17.61M15.07M14.47M15.46M14.85M11.13M10.71M12.67M13.3M13.42M14.79M15.25M14.7M14.96M8.51M7.8M
Cash & Short-Term Investments5.22M3.46M11.03M13.69M12.34M8.14M3.96M1.43M1.44M2.15M2.87M2.21M1.06M1.91M1.56M2.58M1.44M833K10.29M8.95M5.53M5.83M9.08M10.31M9.92M11.58M12.42M12.9M11.11M17K400K
Cash Only5.22M3.46M11.03M13.69M12.34M8.14M3.96M1.43M1.44M2.15M2.87M2.21M1.06M1.91M1.56M2.58M1.44M833K10.29M6.34M3.95M1.3M8.12M10.31M9.92M11.58M12.42M12.9M11.11M17K400K
Short-Term Investments00000000000000000002.6M1.57M4.54M957K00000000
Accounts Receivable12.22M13.22M12.66M4.85M4.13M4.82M4.58M7.06M6.88M5.24M4.38M3.15M3.32M4.67M4.11M4.76M3.8M3.88M4.45M5.14M4.35M4.02M2.95M2.47M2.57M2.37M2.21M1.23M1.3M7.13M6.5M
Days Sales Outstanding163.16171.85163.0982.9676.3199.8893.62125.11127.3497.7185.3969.3778.6796.8387.9378.2283.284.3985.0482.8777.8980.4665.755.6670.2173.5486.2862.5313.4970.0164.12
Inventory000000000350K250K50K9.42M392K9.36M1.27M836K-3.88M000514K0000000651K0
Days Inventory Outstanding---------11.739.211.86339.0413.45337.6632.6732.24----51.02-------11.51-
Other Current Assets830K1.02M1.18M644K1.01M944K1.15M350K350K350K250K50K865K1.13M360K1.27M9.36M9.27M296K351K651K341K311K50K50K50K50K50K2.31M651K900K
Total Non-Current Assets36.45M37.76M33.94M27.71M25.23M30.34M32.8M43.04M47.56M49.28M52.21M48.11M53.28M64.04M57.37M56.92M50.27M46.15M46.73M48.2M39.78M37.96M34.43M33M31.41M27.6M24.96M22.29M11.96M21.7M25.2M
Property, Plant & Equipment34.78M36.08M32.16M25.92M23.8M28.93M31.32M42.59M46.69M48.49M51.33M47.12M50.04M51.38M53.68M53.27M47.36M43.29M43.86M44.23M34.17M34.99M34.27M32.83M31.18M27.35M24.75M22.06M11.76M20.1M23.4M
Fixed Asset Turnover0.80x0.78x0.88x0.82x0.83x0.61x0.57x0.48x0.42x0.40x0.36x0.35x0.31x0.34x0.32x0.42x0.35x0.39x0.44x0.51x0.60x0.52x0.48x0.49x0.43x0.43x0.38x0.32x2.99x1.85x1.58x
Goodwill1.26M1.26M1.26M1.26M1.26M1.26M1.26M000000000000000000000000
Intangible Assets78K78K78K78K78K78K78K00000000000000000000020K1.04M1.2M
Long-Term Investments0000000000579K579K2.71M2.7M2.69M2.66M2.62M2.62M2.62M000000000000
Other Non-Current Assets326K341K437K443K87K73K137K-2.51B-2.96B-2.91B300K405K536K954K1M997K288K43.53M254K-297.03M-595.39M-338.03M-365.84M-1.1B-589.77M243K209K235K183K563K600K
Total Assets54.73M55.48M60.2M48.16M43.96M45.43M43.65M53.78M57.5M58.18M60.6M54.11M67.53M71.74M73.32M74.53M65.34M60.62M62.2M63.04M50.91M48.67M47.11M46.3M44.83M42.38M40.21M36.99M26.92M30.21M33M
Asset Turnover0.50x0.51x0.47x0.44x0.45x0.39x0.41x0.38x0.34x0.34x0.31x0.31x0.23x0.25x0.23x0.30x0.26x0.28x0.31x0.36x0.40x0.37x0.35x0.35x0.30x0.28x0.23x0.19x1.31x1.23x1.12x
Asset Growth %-22.76%-7.84%24.99%9.57%-3.24%4.07%-18.83%-6.47%-1.16%-4%11.98%-19.86%-5.87%-2.16%-1.63%14.07%7.78%-2.53%-1.35%23.85%4.6%3.32%1.73%3.29%5.77%5.41%8.71%37.4%-10.89%-8.46%5.43%
Total Current Liabilities23.72M23.44M10.4M10.78M5.17M5.89M12.38M8.21M9.47M9.01M8.68M8.7M16.25M11.79M9.65M9.94M7.44M7.98M15.67M14.1M11.67M8.29M7.96M8.03M6.25M5.44M5.1M3.57M5.87M16.55M18.7M
Accounts Payable1.08M607K1.56M315K230K318K683K557K435K359K319K375K421K572K263K278K337K318K262K795K340K555K282K371K145K412K81K101K300K3.69M3.7M
Days Payables Outstanding13.889.6229.769.67.3910.6518.6414.8612.9812.0311.7613.9215.1619.629.497.1312.9911.878.7921.7327.5855.0933.3642.6527.46111.0625.3367.155.465.2964
Short-Term Debt17M18.23M4.16M6.54M1.76M2.42M1.16M1.53M2.12M2.46M2.21M2.67M10.79M4.8M3.93M3.94M3.47M4.89M12.84M12.37M9.88M6.38M6.56M6.8M5.49M4.3M4.13M2.54M1.89M10.93M13.2M
Deferred Revenue (Current)0000000286M382M504M610M719M874M000000793K1.33M1.23M1.02M734K485K505K699K837K573K873K0
Other Current Liabilities4.38M2.7M2.57M1.41M1.09M1.18M1.68M-285.87M0000001.55M1.79M823K755K950K793K1.33M1.23M1.02M126K126K215K190K87K3.11M1.05M1.8M
Current Ratio0.77x0.76x2.52x1.90x3.62x2.56x0.88x1.31x1.05x0.99x0.97x0.69x0.88x0.65x1.65x1.77x2.03x1.81x0.99x1.05x0.95x1.29x1.59x1.66x2.15x2.72x2.99x4.12x2.55x0.51x0.42x
Quick Ratio0.77x0.76x2.52x1.90x3.62x2.56x0.88x1.31x1.05x0.95x0.94x0.68x0.30x0.62x0.68x1.64x1.91x2.30x0.99x1.05x0.95x1.23x1.59x1.66x2.15x2.72x2.99x4.12x2.55x0.47x0.42x
Cash Conversion Cycle149.28--------97.4182.8557.31402.5690.66416.1103.75102.44----76.39-------16.23-
Total Non-Current Liabilities4.3M4.34M19.77M11.1M13.16M15.3M7.62M13.76M16.98M19.28M24.74M20.24M25.12M35.9M38.84M39.42M34.85M29.89M23.59M26.25M17.18M19.53M19.29M21.21M22.6M22M20.3M19.89M9.22M22.03M24.2M
Long-Term Debt0017.34M11.04M12.21M14.32M3.44M1.95M3.33M3.6M5.11M6.92M8.59M19.58M22.39M19.28M17.3M19.74M16.39M21.29M11.38M15.25M18.92M20.11M22.01M21.61M20.3M19.89M8.8M11.94M23.9M
Capital Lease Obligations16.36M4.23M1.5M059K359K3.56M9M10.31M12.27M14.85M9.19M12.19M12.95M13.17M16.71M14.37M7.23M4.67M2.72M3.81M000000031K9.63M0
Deferred Tax Liabilities2.08M115K924K63K822K478K418K2.51M2.96M2.91M4.18M3.4M3.47M3.37M3.28M3.44M3.18M2.92M2.54M2.25M2M828K366K1.1M590K383K000164K200K
Other Non-Current Liabilities0000000000000000000003.45M-261K00000392K296K100K
Total Liabilities28.02M27.79M30.17M21.88M18.33M21.19M20M21.97M26.45M28.29M33.42M28.93M41.37M47.69M48.49M49.36M42.3M37.87M39.26M40.35M28.85M27.82M27.25M29.24M28.84M27.43M25.4M23.46M15.09M38.57M42.9M
Total Debt21.19M22.61M23.23M17.64M14.31M17.47M14.4M16.47M20.17M23.14M27.04M23.12M35.66M41.3M43.23M35.75M29.24M33.67M35.19M36.38M25.07M25.08M25.49M26.92M27.5M25.92M24.43M22.43M10.71M32.5M37.1M
Net Debt15.96M19.15M12.2M3.95M1.98M9.33M10.44M14.69M18.72M20.99M24.16M20.91M34.6M39.39M41.67M33.17M27.8M32.84M24.9M30.04M21.11M23.78M17.36M16.61M17.57M14.34M12.01M9.53M-406K32.48M36.7M
Debt / Equity0.79x0.82x0.77x0.67x0.56x0.72x0.61x0.44x0.55x0.64x0.82x0.76x1.15x1.45x1.74x1.42x1.27x1.29x1.53x1.60x1.14x1.20x1.28x1.58x1.72x1.73x1.65x1.66x0.91x--
Debt / EBITDA5.59x6.11x6.89x3.25x1.90x2.63x-5.73x2.32x2.55x2.81x2.83x5.63x5.48x6.33x4.55x4.26x4.71x4.30x4.14x2.55x2.80x3.12x3.69x4.79x3.58x4.36x4.66x1.04x2.96x3.50x
Net Debt / EBITDA4.21x5.18x3.62x0.73x0.26x1.41x-5.11x2.16x2.31x2.51x2.56x5.46x5.23x6.10x4.22x4.05x4.60x3.05x3.42x2.15x2.65x2.13x2.28x3.06x1.98x2.14x1.98x-0.04x2.96x3.46x
Interest Coverage-1.23x-1.28x1.83x1.63x4.12x2.27x-7.94x2.17x2.14x2.25x2.93x2.60x0.75x1.62x1.43x1.72x1.46x1.35x1.77x1.38x4.50x1.67x1.45x1.17x0.91x1.72x1.53x-1.35x-0.86x
Total Equity26.7M27.69M30.03M26.28M25.63M24.24M23.65M37.59M36.99M35.91M32.85M30.23M30.88M28.49M24.83M25.17M23.04M26.11M22.94M22.69M22.05M20.85M19.86M17.06M15.99M14.95M14.81M13.53M11.83M-8.37M-9.9M
Equity Growth %-37.34%-7.78%14.26%2.55%5.72%2.49%-37.08%1.61%3.01%9.32%8.67%-2.11%8.4%14.74%-1.35%9.23%-11.73%13.81%1.08%2.9%5.78%4.97%16.42%6.71%6.94%0.92%9.49%14.39%241.39%15.51%4.81%
Book Value per Share3.974.194.484.114.074.003.836.346.156.166.015.566.166.395.385.455.005.554.594.534.394.133.903.553.294.203.843.412.48-1.33-1.98
Total Shareholders' Equity23.52M24.03M25.18M22.62M21.63M19.89M19.27M31.81M31.05M29.89M27.17M25.18M26.15M24.05M19.93M20.2M19.57M22.75M19.73M19.54M19.01M18.32M17.55M15.33M14.54M13.79M13.66M12.64M11.1M-8.95M-10.5M
Common Stock10.76M10.76M10.76M10.76M10.76M10.76M10.75M10.75M10.71M10.71M10.6M10.38M10.38M8.58M8.58M0008.88B009.31M9.24M9.2M9.17M9.24M9.75M10.04M11.09M11.09M0
Retained Earnings3.65M4.26M5.82M3.63M3.02M1.69M1.5M8.55M7.9M6.87M4.95M4.02M5.54M6.49M6.81M6.77M6.26M6.21M6.39M5.92M5.44M4.74M3.9M2.67M2.06M1.39M684K-628K-3.33M-23.39M-24.9M
Treasury Stock0000000000000000000000000000000
Accumulated OCI00000000-54.01M-51.67M-53.55M-47.66M0-442K-357K-35.34M-36.66M-36.9M-33.9M-31.98M-31.31M-25.41M-20M-15.14M-10.86M2.41M2.41M2.41M2.41M2.41M-18.5M
Minority Interest3.18M3.66M4.84M3.65M4M4.35M4.38M5.78M5.95M6.03M5.68M5.05M4.73M4.43M4.9M4.97M3.47M3.35M3.21M3.15M3.04M2.53M2.31M1.73M1.45M1.17M1.16M890K731K588K600K

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and capital intensity

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Balance Sheet Erosion Amidst Stagnation

As reported in recent quarterly filings, AMS has seen its total assets contract from $63.5M in 2025Q2 to $54.7M in 2026Q1, a trend that suggests the company is struggling to maintain its asset base while navigating persistent operational headwinds and declining cash reserves.

The contraction in total assets, coupled with a simultaneous rise in debt levels, indicates a weakening financial position that may limit future strategic flexibility. Investors should monitor whether this trajectory reflects a deliberate downsizing of the fleet or an inability to replace aging equipment effectively.

Liquidity Buffer Facing Significant Compression

Based on the latest balance sheet data, the company's current ratio has deteriorated sharply from 2.52 in 2024Q4 to 0.77 in 2026Q1, signaling that current assets are no longer sufficient to cover short-term obligations without potential reliance on external financing or further asset liquidation.

This rapid decline in liquidity suggests that the company's cash runway is narrowing, which may force management to prioritize debt service over growth-oriented capital expenditures. The current ratio falling below unity warrants close investigation into the company's ability to manage near-term working capital requirements.

Leverage Rising Against Declining Equity

According to the provided financial statements, the debt-to-equity ratio has climbed from 0.66 in 2024Q2 to 0.79 in 2026Q1, reflecting a shift toward higher leverage at a time when the company's underlying profitability remains under significant pressure.

While the absolute debt level remains manageable, the upward trend in leverage during a period of negative net margins suggests that debt is being used to fund operations rather than growth. This reliance on debt to bridge the cash flow gap may increase the company's sensitivity to interest rate fluctuations.

Asset Quality and Depreciation Risks

As indicated by the quarterly balance sheet, net property, plant, and equipment (PPE) has fluctuated significantly, reaching $34.8M in 2026Q1, which highlights the company's heavy reliance on aging medical hardware that requires constant, capital-intensive maintenance to remain clinically viable.

The high concentration of assets in medical equipment suggests that the company's value is tied to the technological relevance of its fleet. If utilization rates do not improve, the carrying value of these assets may be subject to future impairment risks, further pressuring the equity base.

AMS — Frequently Asked Questions

Quick answers to the most common questions about buying AMS stock.

What are the total assets of American Shared Hospital Services (AMS)?

As of 2025, American Shared Hospital Services (AMS) had total assets of $55.5M including $17.7M in current assets.

How much debt does American Shared Hospital Services (AMS) have?

American Shared Hospital Services (AMS) carries total debt of $22.6M, offset by $3.5M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of American Shared Hospital Services?

American Shared Hospital Services (AMS) has total shareholders' equity (book value) of $24.0M ($4.19 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is American Shared Hospital Services's current ratio and liquidity?

American Shared Hospital Services (AMS) reported a current ratio of 0.76x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.